BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 21103389)

  • 1. Structural features of cytochromes P450 and ligands that affect drug metabolism as revealed by X-ray crystallography and NMR.
    Gay SC; Roberts AG; Halpert JR
    Future Med Chem; 2010 Sep; 2(9):1451-68. PubMed ID: 21103389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and function of cytochromes P450 2B: from mechanism-based inactivators to X-ray crystal structures and back.
    Halpert JR
    Drug Metab Dispos; 2011 Jul; 39(7):1113-21. PubMed ID: 21502194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of cytochrome P450 CYP119 ligand-dependent conformational dynamics by two-dimensional NMR and X-ray crystallography.
    Basudhar D; Madrona Y; Kandel S; Lampe JN; Nishida CR; de Montellano PR
    J Biol Chem; 2015 Apr; 290(16):10000-17. PubMed ID: 25670859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone.
    Williams PA; Cosme J; Vinkovic DM; Ward A; Angove HC; Day PJ; Vonrhein C; Tickle IJ; Jhoti H
    Science; 2004 Jul; 305(5684):683-6. PubMed ID: 15256616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational diversity and ligand tunnels of mammalian cytochrome P450s.
    Yu X; Cojocaru V; Wade RC
    Biotechnol Appl Biochem; 2013; 60(1):134-45. PubMed ID: 23587001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsomal cytochrome P450 2C5: comparison to microbial P450s and unique features.
    Williams PA; Cosme J; Sridhar V; Johnson EF; McRee DE
    J Inorg Biochem; 2000 Aug; 81(3):183-90. PubMed ID: 11051563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity.
    Lewis DF; Ito Y
    Xenobiotica; 2009 Aug; 39(8):625-35. PubMed ID: 19514836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Function Analysis of the Essential
    Padayachee T; Lamb DC; Nelson DR; Syed K
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450.
    Poulos TL
    Curr Opin Struct Biol; 1995 Dec; 5(6):767-74. PubMed ID: 8749364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR studies of ligand binding to P450(eryF) provides insight into the mechanism of cooperativity.
    Roberts AG; Díaz MD; Lampe JN; Shireman LM; Grinstead JS; Dabrowski MJ; Pearson JT; Bowman MK; Atkins WM; Campbell AP
    Biochemistry; 2006 Feb; 45(6):1673-84. PubMed ID: 16460014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-dimensional NMR and all-atom molecular dynamics of cytochrome P450 CYP119 reveal hidden conformational substates.
    Lampe JN; Brandman R; Sivaramakrishnan S; de Montellano PRO
    J Biol Chem; 2010 Mar; 285(13):9594-9603. PubMed ID: 20097757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity.
    Williams PA; Cosme J; Sridhar V; Johnson EF; McRee DE
    Mol Cell; 2000 Jan; 5(1):121-31. PubMed ID: 10678174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do mammalian cytochrome P450s show multiple ligand access pathways and ligand channelling?
    Schleinkofer K; Sudarko ; Winn PJ; Lüdemann SK; Wade RC
    EMBO Rep; 2005 Jun; 6(6):584-9. PubMed ID: 16028306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling human cytochromes P450 involved in drug metabolism from the CYP2C5 crystallographic template.
    Lewis DF
    J Inorg Biochem; 2002 Sep; 91(4):502-14. PubMed ID: 12237218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cytochromes P450 and b5 and their reductases--promising targets for structural studies by advanced solid-state NMR spectroscopy.
    Dürr UH; Waskell L; Ramamoorthy A
    Biochim Biophys Acta; 2007 Dec; 1768(12):3235-59. PubMed ID: 17945183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Your Crystal Structure Will Not Tell You about Enzyme Function.
    Pochapsky TC; Pochapsky SS
    Acc Chem Res; 2019 May; 52(5):1409-1418. PubMed ID: 31034199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structures of prostacyclin synthase and its complexes with substrate analog and inhibitor reveal a ligand-specific heme conformation change.
    Li YC; Chiang CW; Yeh HC; Hsu PY; Whitby FG; Wang LH; Chan NL
    J Biol Chem; 2008 Feb; 283(5):2917-26. PubMed ID: 18032380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural diversity of human xenobiotic-metabolizing cytochrome P450 monooxygenases.
    Johnson EF; Stout CD
    Biochem Biophys Res Commun; 2005 Dec; 338(1):331-6. PubMed ID: 16157296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Dynamics Simulations of a Cytochrome P450 from
    Faponle AS; Roy A; Adelegan AA; Gauld JW
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34204747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure of microsomal cytochrome P450 2C5: a steroid and drug metabolizing enzyme.
    Johnson EF; Wester MR; Stout CD
    Endocr Res; 2002 Nov; 28(4):435-41. PubMed ID: 12530646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.